Latest market price
16.47
-1.29-7.26%
TA
Loading chart...
Snapshot
| Index | — | P/E | — | EPS (ttm) | -4.16 | Insider Own | 5.21% | Shs Outstand | 16.94M | Perf Week | -10.34% |
| Market Cap | 278.96M | Forward P/E | — | EPS next Y | -1.76 | Insider Trans | 5.42% | Shs Float | 12.78M | Perf Month | -18.34% |
| Enterprise Value | 170.96M | PEG | — | EPS next Q | -0.82 | Short Float | 4.03% | Perf Quarter | -11.31% | ||
| Income | -67.00M | P/S | 1.95 | EPS this Y | — | Short Ratio | 2.42 | Perf Half Y | -0.18% | ||
| Sales | 143.00M | P/B | 3.00 | EPS next Y | — | ROA | -44.00% | Short Interest | 514.99K | Perf YTD | 4.57% |
| Book/sh | 5.49 | P/C | 2.56 | EPS next 5Y | — | ROE | -49.17% | 52W High | 27.24 -39.54% | Perf Year | 16.40% |
| Cash/sh | 6.44 | P/FCF | — | EPS past 3/5Y | — | ROIC | -42.66% | 52W Low | 11.37 44.85% | Perf 3Y | 184.95% |
| Dividend Est. | — | EV/EBITDA | — | Sales past 3/5Y | 91.99% 7.20% | Gross Margin | 62.61% | Volatility | 7.51% 7.49% | Perf 5Y | -85.63% |
| Dividend TTM | — | EV/Sales | 1.20 | EPS Y/Y TTM | — | Oper. Margin | -35.20% | ATR (14) | 1.50 | Perf 10Y | — |
| Dividend Ex-Date | Feb 17, 2016 | Quick Ratio | 3.66 | Sales Y/Y TTM | 169.81% | Profit Margin | -47.43% | RSI (14) | 33.64 | Recom | 2.00 |
| Dividend Gr. 3/5Y | -35.09% -21.51% | Current Ratio | 4.04 | EPS Q/Q | 35.37% | SMA20 | -14.52% | Beta | 0.37 | Target Price | 42.50 |
| Payout | 0.00% | Debt/Eq | 0.01 | Sales Q/Q | 155.56% | SMA50 | -25.11% | Rel Volume | 1.23 | Prev Close | 17.76 |
| Employees | 98 | LT Debt/Eq | 0.00 | Earnings | Nov 09 | SMA200 | -15.97% | Avg Volume | 215.82K | Price | 16.47 |
| IPO Date | Jul 16, 2021 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 36.90% -6.74% | Net Debt/EBITDA | — | Volume | 266,265 | Change | -7.26% |
Analyst Ratings
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Oct-26-26 | Initiated | Maxim | Buy | $41 |
| Oct-12-26 | Reiterated | Loop Capital Markets | $54 | |
| Sep-17-26 | Initiated | Craig-Hallum | Buy | $40 |
| Jul-15-26 | Reiterated | Lake Street | $29 → $35 | |
| Feb-11-26 | Initiated | Roth Capital | Buy | $36 |
Latest News· Times ET
Oct-26-26
Oct-26-2608:28AM
Oct-14-26
Oct-14-2609:00AM
Oct-12-26
Oct-12-2609:28AM
Oct-07-26
Oct-07-2609:35AM
Oct-02-26
Oct-02-2608:25PM
Sep-28-26
Sep-28-2611:31AM
Sep-25-26
Sep-25-2604:15AM
Sep-21-26
Sep-15-26
Sep-15-2606:25AM
Aug-27-26
Aug-27-2609:43AM
Aug-26-26
Aug-26-2608:38AM
Aug-24-26
Aug-22-26
Aug-20-26
Company
Prenetics Global Limited is a consumer health sciences company that has pivoted to focus on a consumer health and longevity platform. The company's main brand is IM8, which offers science-backed nutritional supplements. It also operates CircleDNA, a consumer genetic testing brand that provides personalized health reports based on sequencing technology.
Ownership
Per-holder 13F data hasn't been ingested for this ticker yet.
Financial Statements
DataTimeframe
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 143 | 92 | 31 | 22 | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 54 | 44 | 15 | 13 | — | — | — | — | |
| Gross Profit | 89 | 49 | 15 | 9 | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 131 | 80 | 55 | 50 | — | — | — | — | |
| Research and Development | 4 | 5 | 11 | 12 | — | — | — | — | |
| Other Operating Expense | 4 | 2 | -2 | -1 | — | — | — | — | |
| Operating Income | -50 | -38 | -48 | -52 | — | — | — | — | |
| Interest Expense | 0 | 0 | 0 | 0 | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | -22 | 2 | -9 | -5 | — | — | — | — | |
| Net Income Before Taxes | -71 | -36 | -58 | -57 | — | — | — | — | |
| Income Taxes | 0 | 0 | -8 | 0 | — | — | — | — | |
| Consolidated Net Income | -67 | -38 | -46 | -63 | — | — | — | — | |
| Net Income From Continuing Operations | -71 | -36 | -50 | -56 | — | — | — | — | |
| Net Income | -67 | -38 | -46 | -63 | — | — | — | — | |
| EPS (Recurring) | -4.16 | -2.68 | -3.64 | -5.58 | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | -4.16 | -2.68 | -3.64 | -5.58 | — | — | — | — | |
| EPS (Diluted) | -4.16 | -2.68 | -3.64 | -5.58 | — | — | — | — | |
| EBITDA | -64 | -32 | -52 | -48 | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | — | — | — | — | — | — | — | — | |
| Price To Sales Ratio | 1.96 | 2.40 | 2.43 | 2.96 | — | — | — | — | |
| Gross Margin | 62.24 | 53.26 | 48.39 | 40.91 | — | — | — | — | |
| Operating Margin | -34.97 | -41.30 | -154.84 | -236.36 | — | — | — | — | |
| Net Margin | -46.85 | -41.30 | -148.39 | -286.36 | — | — | — | — | |
| Shares Outstanding | 17 | 14 | 13 | 11 | — | — | — | — | |
| Market Capitalization | 280 | 221 | 75 | 65 | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — |
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
Insider Trading
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Leogrande Hudson Blake | Director | Oct 04 '26 | Option Exercise | 0.00 | 2,000 | 0 | 8,001 | Oct 06 |
| Lo Hoi Chun | Chief Financial Officer | Sep 30 '26 | Option Exercise | 0.00 | 7,635 | 0 | 573,648 | Oct 02 |
| Leogrande Hudson Blake | Director | Sep 04 '26 | Option Exercise | 0.00 | 2,000 | 0 | 6,001 | Sep 04 |
| Rosin Brian J | CFO of IM8 (US) LLC | Aug 25 '26 | Buy | 22.80 | 5,100 | 116,280 | 23,100 | Aug 26 |
| Rosin Brian J | CFO of IM8 (US) LLC | Aug 24 '26 | Buy | 21.19 | 18,000 | 381,420 | 18,000 | Aug 26 |
| Yeung Danny Sheng Wu | Chief Executive Officer | Aug 24 '26 | Buy | 21.23 | 17,181 | 364,673 | 112,416 | Aug 24 |
| Lo Hoi Chun | Chief Financial Officer | Aug 21 '26 | Option Exercise | 0.00 | 569,580 | 52 | 566,013 | Aug 24 |
| Yeung Danny Sheng Wu | Chief Executive Officer | Aug 20 '26 | Option Exercise | 0.00 | 863,248 | 86 | 137,647 | Aug 24 |
| Yeung Danny Sheng Wu | Chief Executive Officer | Aug 20 '26 | Buy | 18.31 | 7,500 | 137,325 | 95,235 | Aug 24 |
| Leogrande Hudson Blake | Director | Aug 04 '26 | Option Exercise | 0.00 | 2,001 | 0 | 4,001 | Aug 05 |
| Leogrande Hudson Blake | Director | Jul 04 '26 | Option Exercise | 0.00 | 2,000 | 0 | 2,000 | Jul 07 |
| Cheng Yin Pan | Director | Jun 15 '26 | Option Exercise | 0.00 | 15,873 | 0 | 59,051 | Jun 16 |
| VANDERVEEN DAVID | Director | Jun 15 '26 | Option Exercise | 0.00 | 15,625 | 0 | 45,249 | Jun 16 |
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.